As of 2025-10-20, the Relative Valuation of Syros Pharmaceuticals Inc (SYRS) is (736.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 USD, the upside of Syros Pharmaceuticals Inc based on Relative Valuation is -628930.9%.
The range of the Relative Valuation is (581.05) - (972.40) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.4x | 7.9x |
| Forward P/E multiples | 6.8x - 11.9x | 9.4x |
| Fair Price | (581.05) - (972.40) | (736.99) |
| Upside | -495873.9% - -829792.3% | -628930.9% |
| Date | P/E |
| 2025-10-15 | -0.00 |
| 2025-10-14 | -0.00 |
| 2025-10-13 | -0.00 |
| 2025-10-10 | -0.00 |
| 2025-10-09 | -0.00 |
| 2025-10-08 | -0.00 |
| 2025-10-07 | -0.00 |
| 2025-10-06 | -0.00 |
| 2025-10-03 | -0.00 |
| 2025-10-02 | -0.00 |
| 2025-10-01 | -0.00 |
| 2025-09-30 | -0.00 |
| 2025-09-29 | -0.00 |
| 2025-09-26 | -0.00 |
| 2025-09-25 | -0.00 |
| 2025-09-24 | -0.00 |
| 2025-09-23 | -0.00 |
| 2025-09-22 | -0.00 |
| 2025-09-19 | -0.00 |
| 2025-09-18 | -0.00 |
| 2025-09-17 | -0.00 |
| 2025-09-16 | -0.00 |
| 2025-09-15 | -0.00 |
| 2025-09-12 | -0.00 |
| 2025-09-11 | -0.00 |
| 2025-09-10 | -0.00 |
| 2025-09-09 | -0.00 |
| 2025-09-08 | -0.00 |
| 2025-09-05 | -0.00 |
| 2025-09-04 | -0.00 |
| 2025-09-03 | -0.00 |
| 2025-09-02 | -0.00 |
| 2025-08-29 | -0.00 |
| 2025-08-28 | -0.00 |
| 2025-08-27 | -0.00 |
| 2025-08-26 | -0.00 |
| 2025-08-25 | -0.00 |
| 2025-08-22 | -0.00 |
| 2025-08-21 | -0.00 |
| 2025-08-20 | -0.00 |
| 2025-08-19 | -0.00 |
| 2025-08-18 | -0.00 |
| 2025-08-15 | -0.00 |
| 2025-08-14 | -0.00 |
| 2025-08-13 | -0.00 |
| 2025-08-12 | -0.00 |
| 2025-08-11 | -0.00 |
| 2025-08-08 | -0.00 |
| 2025-08-07 | -0.00 |
| 2025-08-06 | -0.00 |